ResApp Health to join Creasphere Digital Health Program

04Oct

ResApp Health to join Creasphere Digital Health Program

 

Digital health company, ResApp Health (ASX:RAP) has been selected to join the Startup Creasphere Digital Health Program in Munich.

The program is a health-focused accelerator. CEO and Managing Director, Tony Keating says they “are very excited to participate in the Startup Creasphere program to build and pilot a consumer health-focused product using [their] novel respiratory diagnostic algorithms”.

This 12 month collaboration with the consumer healthcare business unit of Sanofi should provide ResApp with an opportunity to explore the direct-to-consumer market alongside global industry leaders.

After the program neither ResApp nor Sanofi has committed to any obligations regarding any of the products created and ResApp retains all intellectual property developed under the program.

Shares in ResApp Health (ASX:RAP) closed 1.82 per cent lower at 27 cents.
Copyright 2019 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

09Jun

Silex Systems (ASX:SLX) rejoices as US DOE amends sales agreement

05 Jun 2020 - R&D company Silex Systems (ASX:SLX) has announced that the 2016 Sales Agreement between Global Laser Enrichment and the US Department of Energy has been amended to better align the agreement with current nuclear fuel market conditions.

Read More
16Apr

Mayne Pharma (ASX:MYX) receives FDA approval for contraceptive pill

16 Apr 2021 - Specialty pharmaceutical company Mayne Pharma (ASX:MYX) has successfully received approval from the US Food and Drug Administration (FDA) for its product NEXTSTELLIS.

Read More
30Apr

Mesoblast (ASX:MSB) commences remestemcel-L trial

30 Apr 2020 - Mesoblast (ASX:MSB) has commenced enrollment for its controlled trial of the remestemcel-L treatment.

Read More
23Sep

Myer Holdings (ASX:MYR) to reduce its board numbers

23 Sep 2020 - Myer Holdings (ASX:MYR) today announced that Non-Executive Directors Lyndsey Cattermole AM and Julie Ann Morrison have decided to retire as Non-Executive Directors at the 2020 Annual General Meeting, and do not intend to seek re-election.

Read More
20Apr

Afterpay (ASX:APT) sets sights on Wall Street listing

20 Apr 2021 - Buy now pay later specialist Afterpay (ASX:APT) has expressed an interest in listing on Wall Street, in light of its shareholder base expanding globally and beyond domestic stock investors.

Read More
19Apr

Telix Pharmaceuticals (ASX:TLX) launches NOBLE Registry

19 Apr 2021 - Telix Pharmaceuticals (ASX:TLX) has announced the launch of the "Nobody Left Behind" ("NOBLE") Registry.

Read More
15Apr

Transurban (ASX:TCL) reports a rise on their road to recovery for the March quarter

15 Apr 2021 - Transurban (ASX:TCL) reported a rise in the average daily traffic of 1.1% compared to last year for the March quarter. Though when compared to 2019, it is down 3.8%. The company said traffic has recovered to pre covid-19 levels where restrictions have lifted.

Read More
27Feb

Evans Dixon (ASX:ED1) set to reduce staff by 20%

27 Feb 2020 - Wealth manager Evans Dixon (ASX:ED1) report statutory NPAT for the half year of $2.1 million was down from $12.4 million delivered in the prior corresponding period.

Read More
01Apr

Brickworks (ASX:BKW) to reopen brick plants in Pennslyvania

01 04 2020 - Brickworks (ASX:BKW) has been advised that it may re-open their brick plants in Pennsylvania.

Read More
02Nov

Stocks of the Hour: Origin Energy, Sunstone Metals, Chimeric Therapeutics

02 Nov 2023 - A snapshot of the stocks on the move, featuring Origin Energy (ASX:ORG), Sunstone Metals (ASX:STM) and Chimeric Therapeutics (ASX:CHM).

Read More